Home > Result Summaries: Compounds > naratriptan > Result Summary for S2WA3012

Result Summary for S2WA3012

Result Summary

Protocol ID:	S2WA3012
Clinical Study ID:	S2WA3012
Official Title:	A randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy, safety and tolerability of oral naratriptan in an adolescent migraine population.
Phase:	Phase 3
Study Indications or Diseases:	Migraine Disorders
Generic Name:	naratriptan
Trade/Product Name:	amerge;naramig
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Abstract: Efficacy and safety of naratriptan tablets in adolescent migraine. Rothnerl, K. Edwards2 L. Kerr3 S. DeBussey4 M. Asgharnejad4 16th World Congress of Neurology 9/14/1997 Buenos Aires, Argentina Rothner A, Efficacy and safety of naratriptan tablets in adolescent migraine. J of NEUROLOGICAL SCIENCES 1997;150(suppl):S106.